Selecting the Best HIPEC Surgeons and Hospitals in India — a Zambian Patient's Guide

Author:- Dr. Dheeraj Bojwani Date Created:- 24-08-2026

Choosing a surgeon and hospital for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS+HIPEC) means choosing a team with genuine, high-volume experience in this specific procedure. In 24 years of guiding patients through cancer care abroad, I have found that few decisions in this entire guide series depend as heavily on accumulated experience as this one — the difference between an experienced and inexperienced centre is measured in a genuinely large mortality gap, not a marginal one.

Healing Journeys of Zambian Patients

Zambian Patients Share Their Experience

Key Takeaways

• The guide explains that CRS+HIPEC is not currently available in Zambia and is a procedure where accumulated surgeon and centre experience is particularly important. Because outcomes are strongly linked to high-volume experience, the guide recommends discussing referral to an experienced Indian centre with the patient's Zambian oncology team.
• The guide stresses that a general surgical oncologist is not automatically a HIPEC-experienced surgeon. CRS+HIPEC has a steep learning curve, and the guide cites published data showing early-experience mortality of around 18% compared with roughly 3% with accumulated centre experience. Patients should therefore ask for specific personal and centre-wide procedure numbers.
• The page 2 framework gives 60% weighting to the HIPEC-experienced surgeon and 40% to the hospital and team. Surgeon assessment focuses on personal CRS+HIPEC case volume, experience with the tumour's origin, explanation of the Peritoneal Cancer Index and expected Completeness of Cytoreduction score, personal complication and mortality rates, and the plan if complete cytoreduction cannot be achieved.
• The hospital assessment focuses on total CRS+HIPEC volume, dedicated ICU or high-dependency support, genuine multidisciplinary tumour-board review and a clear extended-stay and follow-up plan. The page 2 checklist also recommends receiving written operative and pathology reports at discharge.
• The qualification table identifies MBBS, MS General Surgery, MCh/DNB Surgical Oncology and dedicated CRS+HIPEC fellowship or high-volume experience as progressively relevant training. The guide particularly emphasises procedure-specific experience rather than relying only on general surgical oncology credentials.
• For Zambian patients, the guide recommends considering the extended hospital stay and recovery period, arranging for the Zambian oncology team to receive complete operative and pathology reports and checking what the quotation includes, particularly if an extended ICU stay becomes necessary. It also highlights the yellow-fever certificate and Indian Medical Visa requirements before travel.

Quick Facts

Author

Dr. Dheeraj Bojwani

Experience

24+ Years

Treatment

CRS + HIPEC

Patients

Zambian Patients

Key Specialist

HIPEC-Experienced Surgical Oncologist

Selection Weighting

60% surgeon / 40% hospital & team

Key Assessment

Personal CRS+HIPEC case count

Centre Check

Total CRS+HIPEC volume

Tumour Check

Experience with the tumour's origin

Disease Assessment

Peritoneal Cancer Index and expected CC score

Safety Check

Personal complication and mortality rates

Hospital Check

Dedicated ICU/HDU and tumour board

Records

Written operative and pathology reports

Pre-Travel Check

Imaging and oncology records

Follow-Up

Zambian oncology team

Key Warning

Vague or estimated HIPEC case numbers

Decision Principle

Choose genuine high-volume CRS+HIPEC expertise at both surgeon and centre level.

In Brief

For Zambian patients considering CRS+HIPEC in India, the guide recommends prioritising high-volume, procedure-specific experience at both surgeon and centre level. Patients should ask for exact case numbers, tumour-specific experience, personal complication and mortality rates, and a clear plan if complete cytoreduction cannot be achieved.

First, should you travel at all?

CRS+HIPEC is not currently available in Zambia, and given how strongly outcomes depend on centre and surgeon experience specifically, this is a procedure where travelling to a genuinely high-volume centre is clearly the right approach rather than a nearby option with limited experience. Discuss this openly with your Zambian oncology team as part of your referral.

Why "a surgical oncologist" is not the same as a HIPEC-experienced team

General surgical oncologists manage a broad cancer-surgery caseload and may perform CRS+HIPEC only occasionally. This procedure has one of the steepest learning curves in oncology, with published data showing early-experience mortality around 18%, dropping to roughly 3% with accumulated centre experience. Ask directly whether the team proposed for your care has this specific, high-volume experience, not simply general surgical oncology credentials.

This distinction is worth asking about directly, using the surgeon's and hospital's own specific case numbers.

Two decisions, weighted heavily toward the surgeon

Few procedures in this guide series show as strong a link between accumulated experience and survival as CRS+HIPEC, which is why this decision leans further toward the surgeon and team's specific experience than most others covered in this series.

Part One: choosing the surgeon

Ask directly for their personal CRS+HIPEC case count, stated specifically rather than estimated, and their particular experience with your tumour's origin, since colorectal, ovarian, gastric and appendiceal cases each carry their own considerations. Ask them to explain your Peritoneal Cancer Index and expected Completeness of Cytoreduction score honestly, since these numbers meaningfully shape both candidacy and expected outcome. Ask about their personal complication and mortality rates, shared openly rather than deflected to general published statistics.

It is also worth asking what the plan would be if complete cytoreduction turns out not to be achievable once surgery begins, since an incomplete cytoreduction carries the full risk of the operation without the same survival benefit, and a thoughtful surgeon will have a clear, honest answer.

Part Two: choosing the hospital

Ask specifically for the centre's total CRS+HIPEC volume, not just whether the procedure is offered. Confirm a dedicated ICU or high-dependency unit is available for post-operative recovery, since this surgery typically requires a more intensive recovery period than most abdominal procedures. Ask whether a genuine multidisciplinary tumour board reviews candidacy decisions before surgery is scheduled.

Five questions test the surgeon's own experience; the other five test the hospital's readiness.

Cost and value: how to weigh the money honestly

CRS+HIPEC in a good Indian hospital costs a fraction of the equivalent procedure in the West, and India has established genuine high-volume programmes with outcomes comparable to high-income countries. In 24 years of arranging these journeys, I have found that disputes almost never concern the quoted price — they concern what it silently omitted, particularly the cost of an extended ICU stay if recovery proves more complex than expected.

What a Zambian patient should weigh in particular

Payment comes from your own resources, since NHIMA funds care at accredited facilities inside Zambia, not treatment abroad. Given how starkly outcomes depend on accumulated centre and surgeon experience for this specific procedure, insisting on genuine, high-volume expertise, rather than the first available surgical oncologist, is a reasonable way to protect this investment. Arrange for your Zambian oncology team to receive a complete written operative and pathology report before you return home.

If a family member is able to accompany you, consider the practical value of having support present given the typically extended hospital stay and recovery period this procedure involves.

The practical journey from Zambia

India requires a yellow fever vaccination certificate from travellers arriving from Zambia, valid only from ten days after the injection. Your medical visa is issued by the High Commission of India on Pandit Nehru Road in Lusaka against the hospital's invitation letter; given the extended stay this procedure typically requires, plan accordingly. There is no direct flight from Zambia to India; you will connect through Addis Ababa on Ethiopian Airlines, or through Dubai, Doha or Nairobi.

Four signals that should make you pause

1. A surgeon who cannot state their personal CRS+HIPEC case count specifically.

2. No clear centre-wide volume figure for this procedure.

3. No genuine multidisciplinary tumour board reviewing your candidacy.

4. No clear plan discussed for what happens if complete cytoreduction is not achievable.

This single question reveals whether a centre has the specific, accumulated experience this procedure demands.

Straight Answers for Zambians about HIPEC Surgeons and Hospitals in India

Sources

• 🌐 Medical visa, Lusaka — High Commission of India, requirements & process: hcizambia.gov.in/page/medical-visa
• 🌐 Hospital accreditation (India) — Verify a hospital's NABH accreditation: nabh.co
• 🌐 National Health Insurance (Zambia) — NHIMA cover, treatment abroad is not covered: nhima.co.zm
• 🌐 Ministry of Health Zambia — National health services & guidance: moh.gov.zm
• 🌐 National Medical Commission (verify a surgeon) — Confirm a surgeon's registration in India: nmc.org.in
• 🌐 WHO yellow fever — Vaccination requirements before travel: who.int/health-topics/yellow-fever

A Closing Word

Of everything I help patients verify, confirming genuine, high-volume CRS+HIPEC experience at both the surgeon and centre level is among the most protective steps you can take. If you send me your imaging and case history, I will help you understand honestly what your options are, and which centres in India have the accumulated experience this demanding procedure genuinely requires.

Frequently Asked Questions by Zambians about HIPEC Surgeons and Hospitals in India

Should Zambian patients travel to India for HIPEC?

The guide states that CRS+HIPEC is not currently available in Zambia and recommends considering a genuinely high-volume centre because experience has a particularly strong relationship with outcomes for this procedure.

Is every surgical oncologist qualified to perform HIPEC?

Not necessarily. CRS+HIPEC has a steep learning curve, so patients should verify specific, high-volume CRS+HIPEC experience rather than relying only on general surgical oncology qualifications.

How many HIPEC procedures should a surgeon have performed?

The guide does not provide a universal minimum number. Instead, it recommends asking for the surgeon's exact personal CRS+HIPEC case count and comparing it with the centre's total volume.

Why does centre volume matter?

The guide highlights a strong volume-outcome relationship for CRS+HIPEC and cites published data showing a substantial difference between early-experience and accumulated high-volume experience.

Does the tumour's origin matter?

Yes. The guide recommends asking about experience with the specific tumour origin, including colorectal, ovarian, gastric and appendiceal cancers, because each presents different considerations during CRS+HIPEC.

What are PCI and the CC score?

The Peritoneal Cancer Index (PCI) helps describe the extent of peritoneal disease, while the expected Completeness of Cytoreduction (CC) score reflects how completely visible tumour may be removed. The guide recommends asking the surgeon to explain both honestly.

What should I check about the hospital?

Confirm the centre's total CRS+HIPEC volume, a dedicated ICU or high-dependency unit, genuine multidisciplinary tumour-board review and a clear plan for the extended postoperative stay.

What happens if complete cytoreduction cannot be achieved?

The guide recommends asking this before surgery. An experienced surgeon should have a clear plan for this possibility rather than leaving the decision unexplained until the operation.

What records should I take back to Zambia?

Obtain the complete written operative and pathology reports and ensure they are provided to your Zambian oncology team for continuing care.

What are the main warning signs?

Be cautious if the surgeon cannot state their personal HIPEC case count, the centre will not provide its total volume, there is no genuine tumour board or there is no clear plan for incomplete cytoreduction.

Page Summary

This guide helps Zambian patients compare HIPEC surgeons and hospitals in India, focusing on personal CRS+HIPEC experience, centre volume, tumour-specific expertise, Peritoneal Cancer Index and cytoreduction assessment, ICU support and multidisciplinary tumour-board care. The page 2 framework gives 60% weight to the surgeon and 40% to the hospital and team, while the page 4 diagram highlights the most important question: how many CRS+HIPEC procedures has the centre performed, and what is the surgeon's personal count?

Citation Block

Topic	Information
Topic	Selecting the Best HIPEC Surgeons & Hospitals in India for Zambian Patients
Treatment	CRS + HIPEC
Patients	Zambian Patients
Key Specialist	HIPEC-Experienced Surgical Oncologist
Selection Weighting	60% surgeon / 40% hospital & team
Key Training	Dedicated CRS+HIPEC fellowship / high-volume experience
Surgeon Experience	Personal CRS+HIPEC case count
Centre Experience	Total CRS+HIPEC volume
Tumour Expertise	Colorectal, ovarian, gastric, appendiceal and other tumour origins
Disease Assessment	Peritoneal Cancer Index and expected CC score
Outcome Check	Personal complication and mortality rates
Surgical Contingency	Plan if complete cytoreduction is not achievable
Hospital Support	Dedicated ICU/HDU
Tumour Board	Genuine multidisciplinary candidacy review
Recovery Plan	Extended hospital stay and follow-up
Records	Written operative and pathology report
Pre-Travel Review	Imaging and cancer history
Warning Signs	Vague case numbers, no centre volume, no tumour board or no plan for incomplete cytoreduction
Travel Requirements	Yellow-fever certificate and Indian Medical Visa
Key Decision	Prioritise high-volume CRS+HIPEC expertise at both surgeon and centre level